Partners Group has completed a program valued at over $15 billion.
Criteria Caixa has sold its 2.64% stake in Cellnex for $660 million.
GSK has expressed satisfaction with the dismissal of a U.S. lawsuit related to Zantac, its heartburn medication.
Avolta, through its subsidiary HMSHost, has si…
© MarketScreener.com 2024
Criteria Caixa has sold its 2.64% stake in Cellnex for $660 million.
GSK has expressed satisfaction with the dismissal of a U.S. lawsuit related to Zantac, its heartburn medication.
Avolta, through its subsidiary HMSHost, has si…
© MarketScreener.com 2024